{
  "docId": "019de074-4761-73aa-b4e2-27087123bde2",
  "docSlug": "6f8a02d6c80778306574b231840d422a",
  "documentTitle": "argenx SE | Investor Presentation Deck | 23 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 23,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a waterfall-style bar chart to show quarterly revenue growth throughout the first year of product launch.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-4761-73aa-b4e2-27087123bde2/7",
  "deckHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2",
  "deckJsonHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2.json",
  "deckAnchorHref": "/decks/019de074-4761-73aa-b4e2-27087123bde2#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.41,
        "x": 0.295,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Quarterly revenue growth from 1Q to 4Q",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "851bab86-edfc-4fc3-ad60-cf9b41aa75f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "VYVGART launched in U.S., Japan & Germany; Submissions in 10+ countries; Built scalable global supply chain; Large scale capacity to handle demand; Rapid HCP adoption; 90% of key targets reached; Enabled appropriate access; 90% US policies favorable",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd46d99d-90e8-40c2-b83e-e7f08a94077d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.15,
        "x": 0.36,
        "y": 0.35
      },
      "kind": "metric",
      "text": "$402M global product revenues in Year 1",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "032f7511-2135-4e68-a747-f573567907d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.3,
        "y": 0.85
      },
      "kind": "subtitle",
      "text": "More than 3,000 patients on VYVGART®",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00654bb1-a112-4648-b23b-423962406d23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.6,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "2022: Transformed into an Integrated Immunology Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e57b45cd-dee1-4ed3-a3bf-42fe9229e0b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "ed9da21d-e6e8-4e23-86d3-b6488e5b4440",
      "evidence": "The use of a bar chart to display revenue growth suggests a consideration of chart selection principles.",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "5ac7fe01-ee88-430d-8f96-b18ac3ce46a5",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What Is",
      "beatSlug": "sparkline-what-is-3",
      "evidence": "Overview of argenx SE's current status",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "f920d6a4-4c5b-4afa-b354-8572799f0392",
      "evidence": "The presentation explains the rationale behind argenx SE's precision medicine approach",
      "position": 0,
      "objective": "Why argenx SE's approach matters",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}